Pharmaceutical company Cosette Pharmaceuticals Inc revealed on Monday that it has acquired G&W Laboratories' finished dosage manufacturing plant located in Lincolnton, NC, expanding Cosette's capabilities into new dosage forms.
Financial details of the acquisition were not disclosed.
Walt Kaczmarek, president and chief executive officer of Cosette, said: "The Lincolnton facility has an excellent track record of producing liquid pharmaceuticals along with other differentiated dosage forms, and operates as a contract manufacturer across multiple presentations for select business partners. We look forward to integrating their expertise and capabilities to the Cosette family and adding value to the Cosette growth pathway."
Cosette Pharmaceuticals specializes in the areas of dermatology and allergy, with products available in dosage forms such as creams, ointments, lotions, solutions, gels, pastes and suppositories.
Inimmune signs research collaboration with Boston Children's Hospital
ResVita Bio receives USD250,000 phase one Small Business Innovation Research grant from NIAID
Phase II Data of Oral Dexpramipexole Published in Eosinophilic Asthma
AllerVie Health Rebrands Southern Allergy & Asthma
Applied BioCode Inks Distribution Agreement with Medline Industries
Vedanta Biosciences Receives Fast Track Designation for VE303
KalVista Pharmaceuticals Presents Data at 13th C1-inhibitor Deficiency & Angioedema Workshop
French Ophthalmology Specialist Horus Pharma Group Launches a Nordic Subsidiary